Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Cellophil™ is a platform of novel polymers based on amino-acid groups. The platform polymers show superior biocompatibility and can be loaded with drugs for controlled release. More
Cripto-1 expression increases the expression of TNF-alpha in CD4+ T cells in tissues affected by chronic inflammatory disease. More
This TACE inhibitory protein could be used as a new therapeutic agent against chronic inflammatory diseases that are mediated by TNF-alpha. More
New Science Solutions for Clinical Development More
Related Reports
Market Research Reports provided by reports.iptechex.com
Nov 2010 - 217 pages - $1,495
Dec 2010 - 33 pages - $5,700
Dec 2010 - 33 pages - $500
Jan 2008 - 148 pages - $1,740
Apr 2011 - 43 pages - $500
Aug 2011 - 45 pages - $500
Jul 2006 - 240 pages - $3,500
Nov 2010 - 50 pages - $500
Aug 2011 - 81 pages - $3,835
Oct 2011 - 25 pages - $2,000
Your selection
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us